Utrecht-based startup that develops and distributes bioreactor technology for stem cell cultivation
Scinus Group has raised €3.0M across 1 funding round from 3 investors, most recently a round in Mar 2026. Based in Utrecht, Netherlands; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2026-03-16 | Other | €3.0M |
| company founders,Demcon Innovation Fund,Myosotis Investments |
| View deal → |
